已收盘 08-01 16:00:00 美东时间
-0.230
-0.70%
今日重点评级关注:瑞银:维持泰尼特"买入"评级,目标价从230美元升至238美元;杰富瑞:维持BellRing Brands"买入"评级,目标价从80美元升至82美元
07-24 09:49
Clearway Energy, Inc.(纽交所:CWEN.A)的市盈率为39倍,可能在美国市场看起来像是一个强烈的卖出信号,因为大约一半的公司市盈率低于1...
07-22 00:33
CIBC analyst Mark Jarvi downgrades Clearway Energy (NYSE:CWEN) from Outperformer to Neutral and announces $35 price target.
07-21 23:05
Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) will release its Second Quarter 2025 financial results on August 5, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time. The live webcast, along with presentation materials, will be available on the Company’s website at http://www.clearwayenergy.com under the "Presentations & Webcasts" section. The webcast will also be archived for later viewing. Clearway Energy, Inc. is o...
07-10 20:30
Clearway Energy ( ($CWEN) ) has provided an update. On June 30, 2025, Clearway ...
07-08 05:50
Clearway Energy (NYSE:CWEN) declares $0.4384/share quarterly dividend. Forward yield 5.98% Payable June 16; for shareholders of record June 2; ex-div June 2. See CWEN Dividend Scorecard, Yield Chart, ...
05-01 05:25
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1111574370732224512.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Larimar Therapeutics(LRMR)"买入"评级,目标价从15美元升至16美元</p> <p>• HC Wainwright & Co.:维持Au
03-26 08:45
Value and growth - two important factors traders and investors look for when allocating their capital towards the market. With Wall Street stumbling in 2025, it may seem challenging to find names that...
03-21 01:12
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1101791398596456448.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler:维持Prothena Corp(PRTA)"超配"评级,目标价从94美元升至110美元</p> <p>• HC Wainwright & Co.:维持Karyopharm Therape
02-27 11:06